Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
Robert A. Kyle(Mayo Clinic in Arizona), Brian G.M. Durie(Cedars-Sinai Medical Center), S. Vincent Rajkumar(Mayo Clinic in Arizona), Ola Landgren(National Cancer Institute), Joan Bladé(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Giampaolo Merlini, Nicolaus Kröger(Universität Hamburg), Hermann Einsele(University of Würzburg), David H. Vesole(Hackensack University Medical Center), Meletios Α. Dimopoulos(National and Kapodistrian University of Athens), Jesús F. San Miguel(Centro de Investigación del Cáncer), Hervé Avet‐Loiseau, Roman Hájek(University Hospital Brno), W M Chen(Beijing Chaoyang Emergency Medical Center), Kenneth C. Anderson(Dana-Farber Cancer Institute), Heinz Ludwig(Wilhelminen Hospital), Pieter Sonneveld(Erasmus University Rotterdam), S Pavlovsky, Antonio Palumbo(University of Turin), Paul G. Richardson(Dana-Farber Cancer Institute), Bart Barlogie, Patricia T. Greipp(Mayo Clinic), Robert Vescio(Cedars-Sinai Medical Center), Ingemar Turesson(Lund University), Jan Westin(Sahlgrenska University Hospital), Mario Boccadoro(University of Turin), on behalf of the International Myeloma Working Group
Cited by 874Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis